These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29145305)

  • 1. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis.
    Yang Y; Wu K; Liu Y; Shi L; Tao K; Wang G
    Medicine (Baltimore); 2017 Nov; 96(46):e8690. PubMed ID: 29145305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis.
    Li H; Yan M; Wu X; Wang Y; Huang L
    Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.
    Zhu H; Luo H; Zhu X; Hu X; Zheng L; Zhu X
    Oncotarget; 2017 Jan; 8(1):1628-1640. PubMed ID: 27911861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of pyruvate kinase M2 expression in esophageal squamous cell carcinoma and its meta-analysis.
    Zhang Q; Zheng S; Liu Q; Liu T; Tuerxun A; Yang L; Han X; Lu X
    Transl Cancer Res; 2021 Jun; 10(6):2643-2652. PubMed ID: 35116577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
    Zhang Y; Sun Y; Zhang Q
    Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PKM2 promotes stemness of breast cancer cell by through Wnt/β-catenin pathway.
    Zhao Z; Song Z; Liao Z; Liu Z; Sun H; Lei B; Chen W; Dang C
    Tumour Biol; 2016 Mar; 37(3):4223-34. PubMed ID: 26493994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.
    Wu J; Hu L; Chen M; Cao W; Chen H; He T
    Onco Targets Ther; 2016; 9():4277-88. PubMed ID: 27478385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival.
    Al-Keilani MS; Bdeir R; Elstaty RI; Alqudah MA
    BMC Cancer; 2023 Feb; 23(1):158. PubMed ID: 36797689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and clinicopathologic significance of nm23 in various cancers: A systematic review and meta-analysis.
    Liu L; Li M; Zhang C; Zhang J; Li G; Zhang Z; He X; Fan M
    Int J Surg; 2018 Dec; 60():257-265. PubMed ID: 30389538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
    He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
    J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Li Y; He M; Zhou Y; Yang C; Wei S; Bian X; Christopher O; Xie L
    Front Pharmacol; 2019; 10():139. PubMed ID: 30873025
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
    Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
    Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma.
    Pu H; Zhang Q; Zhao C; Shi L; Wang Y; Wang J; Zhang M
    World J Surg Oncol; 2015 Nov; 13():323. PubMed ID: 26607846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.
    Zhang Z; Fang T; Lv Y
    World J Surg Oncol; 2022 Nov; 20(1):361. PubMed ID: 36372891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinical value of Sirt1 expression in gastric cancer: A systematic meta-analysis.
    Jiang B; Chen JH; Yuan WZ; Ji JT; Liu ZY; Wu L; Tang Q; Shu XG
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):278-284. PubMed ID: 27072976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.